NY doctors test power of tradipitant to slow, stop progression of COVID-19 pneumonia

As experts around the globe try to understand and get ahead of COVID-19, New York doctors and researchers are testing the power of a drug called tradipitant in treating COVID-19 pneumonia.

News 12 Staff

Apr 22, 2020, 12:22 AM

Updated 1,495 days ago

Share:

As experts around the globe try to understand and get ahead of COVID-19, New York doctors and researchers are testing the power of a drug called tradipitant in treating COVID-19 pneumonia.

Dr. Bushra Mina, of Northwell Health's Lenox Hill Hospital in New York City, is leading the study with Vanda Pharmaceuticals.
He says tradipitant could possibly stop or slow the progression of the disease on the body.

Mina says 300 patients will be involved in the study, and the drug will be administered via pills.

Tradipitant is currently in clinical development for atopic dermatitis, an itchy inflammation of the skin, gastroparesis, weakness of stomach muscles and motion sickness.
Dr. Mina says the study and analysis should take a few months before FDA approval.
PHOTOS: COVID-19 Survivor Photos
undefined
 


More from News 12